Literature DB >> 7150951

Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas.

B H Westerink, S J Spaan.   

Abstract

Administration of the MAO-inhibitor pargyline resulted in an increase of dopamine (DA) and an exponential decrease of the metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas. From these curves the rate of formation of DA and the rate of removal of DOPAC were calculated, within one experiment, for the striatum, tuberculum olfactorium and frontal cortex. When the accumulation rate of 3-methoxytyramine was taken into account it appeared that the rate of DA formation was in good agreement with the rate of DOPAC removal in the brain areas studied. The contribution of the DA formation to the synthesis of noradrenaline in the frontal cortex appeared negligible. The earlier reported rapid rise of striatal DA levels after administration of aminotetralin-derived DA agonists suggests that the synthesis rate of the biogenic amine is higher than its rate of metabolism. It appeared from the present study that an increased rate of synthesis of DA induced by the DA agonists was responsible for this discrepancy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150951     DOI: 10.1016/0006-8993(82)90391-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine.

Authors:  Chad A Bousman; Mariana Cherner; Stephen J Glatt; J Hampton Atkinson; Igor Grant; Ming T Tsuang; Ian P Everall
Journal:  Neurobehav HIV Med       Date:  2010-01-01

2.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

3.  Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.

Authors:  S M Lasley; R D Greenland; D J Minnema; I A Michaelson
Journal:  Neurochem Res       Date:  1984-12       Impact factor: 3.996

4.  Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.

Authors:  F Karoum; S J Chrapusta; R Brinjak; A Hitri; R J Wyatt
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

5.  Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.

Authors:  E Tavitian; L Peyrin; Y Dalmaz; R Favre; M De Haut; J M Cottet-Emard
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

6.  Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.

Authors:  Mariana Cherner; Caitlin W-M Watson; Rowan Saloner; Laura E Halpin; Arpi Minassian; Sarah S Murray; Florin Vaida; Chad Bousman; Ian Everall
Journal:  Addict Behav       Date:  2019-06-12       Impact factor: 4.591

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.